BlackRock cuts voting rights attached to ChemoMetec shares to 14.97%
BLK•BlackRock reduced voting rights attached to ChemoMetec shares to 14.97% on Oct. 15, below the 15% threshold. Total voting rights remained 15.08%, while rights attached to financial instruments rose to 0.11%.
1. Voting rights disclosure
BlackRock reduced voting rights attached to ChemoMetec shares to 14.97% on Oct. 15, 2026, below the 15% threshold. Voting rights attached to financial instruments rose to 0.11%, while total voting rights remained unchanged at 15.08%, the Oct. 21 disclosure said.
